A biologist's perspective on malaria vaccine development

Human Vaccines
Robert Sinden

Abstract

A vaccine to reduce human suffering caused by malarial parasites has been the holy grail of malaria research. Early studies in the 1940s indicated that attenuated parasites could induce useful immunity. Since that time the genomic revolution led inevitably to the idea of cheap production of safe recombinant vaccines using either expressed protein or DNA vector technologies. It has been difficult to reflect with these 'simple' formulations the efficacies observed with intact parasite immunogens. With the new-found ability to attenuate the parasites by genetic manipulation, ideas have come full circle. Some of the highs and lows of this journey are described from the specific viewpoint of our growing understanding of parasite biology. The objective of many current vaccine initiatives targeting morbidity and mortality is questioned in the light of renewed calls to consider eradication as an objective. The biological rational for approaches to limit parasite transmission are highlighted and their place in future efforts to improve the lives of the 40% of the world's population at risk of the disease is discussed.

Citations

May 9, 2013·Nature Communications·A M BlagboroughR E Sinden
Feb 7, 2014·Malaria Journal·Henri VialKelly Chibale
Dec 24, 2011·Future Microbiology·Nicole Mideo, Sarah E Reece
Jun 25, 2014·Future Microbiology·Krijn Paaijmans, Xavier Fernàndez-Busquets
Jan 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Joel Vega-RodríguezMarcelo Jacobs-Lorena
Jan 20, 2015·Expert Review of Vaccines·Daria NikolaevaSumi Biswas
Aug 28, 2013·Human Vaccines & Immunotherapeutics·Arturo Reyes-Sandoval, Martin F Bachmann
Jun 29, 2012·Human Vaccines & Immunotherapeutics·Mohan BairwaSumit Chawla
Jul 23, 2013·International Journal for Parasitology·Andrew R WilliamsSumi Biswas
Oct 2, 2012·International Journal for Parasitology·Michael J DelvesRobert E Sinden
Sep 3, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B M Greenwood, G A T Targett
Nov 29, 2011·Trends in Parasitology·Miles B Markus
Sep 9, 2011·Memórias do Instituto Oswaldo Cruz·Myriam Arévalo-HerreraSócrates Herrera Valencia
Jun 24, 2017·Science Translational Medicine·Matthew B B McCallRobert W Sauerwein
Sep 20, 2018·Nature Communications·Michael J DelvesJake Baum
Apr 19, 2017·The Journal of Infectious Diseases·Sofía Mira-MartínezAlfred Cortés
Apr 9, 2017·Cold Spring Harbor Perspectives in Medicine·Carole A Long, Fidel Zavala
Feb 26, 2019·Frontiers in Immunology·Jonas A Kengne-OuafoBismarck Dinko
May 12, 2017·Cold Spring Harbor Perspectives in Medicine·Julie HealerAshley J Birkett
May 18, 2021·Frontiers in Cellular and Infection Microbiology·Nicholas C SmithChandra Ramakrishnan
Jun 25, 2021·Parasitology International·Arturo Reyes-Sandoval
Jan 2, 2022·Wiley Interdisciplinary Reviews. RNA·Justin Alexander Davis, Kausik Chakrabarti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Rhoel R DinglasanMarcelo Jacobs-Lorena
Malaria Journal
Mary R Galinski, John W Barnwell
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
B M Greenwood, G A T Targett
© 2022 Meta ULC. All rights reserved